New curcumin analog, CCA-1.1, synergistically improves the antiproliferative effect of doxorubicin against T47D breast cancer cells

An improved compound of pentagamavunone-1 (PGV-1), chemoprevention-curcumin analog 1.1 (CCA-1.1), has been synthesized and proven to have antiproliferative effects against breast cancer cells. This study is designed to investigate the potency of CCA-1.1 alone and in combination with doxorubicin (Dox...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Febri Wulandari, Muthi' Ikawati, Dhania Novitasari, Mitsunori Kirihata, Jun-ya Kato, Edy Meiyanto
Formato: article
Lenguaje:EN
Publicado: Universitas Gadjah Mada 2020
Materias:
Acceso en línea:https://doaj.org/article/9b3e16eefe9341d78d2a4662424780b0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!